Related Experiment Video
Updated: Jan 9, 2026

08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
7.6K
Intelligent Nanomedicine Systems Utilizing Diverse Nanoparticles for Osteosarcoma Therapy: A Review
Jie Cai1, Hulin Yang1, Zongxian He1
1Department of Orthopedics, The First People's Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou, 311200, People's Republic of China.
International Journal of Nanomedicine
|December 4, 2025
Summary
Smart nanomedicine offers new hope for osteosarcoma treatment, improving targeted drug delivery and reducing side effects. Advanced nanoparticle-based therapies aim to prevent recurrence and enhance survival rates for solid tumors.
Area of Science:
- Oncology
- Nanomedicine
- Biotechnology
Background:
- Osteosarcoma treatment relies heavily on surgery, leading to significant functional impairment and high recurrence rates.
- Current therapies face challenges in effectively eliminating residual tumor cells and preventing metastasis.
- Smart nanomedicine presents a promising alternative for targeted and personalized solid tumor treatment.
Purpose of the Study:
- To explore the potential of smart nanomedicine in improving osteosarcoma therapy.
- To highlight the role of nanoparticles in targeted drug delivery and reducing damage to healthy tissues.
- To discuss the integration of AI and big data in developing advanced nanomedicine systems.
Main Methods:
- Review of current nanomedicine strategies for solid tumor treatment.
- Analysis of nanoparticle applications in targeted drug delivery and immunotherapy.
- Discussion on the integration of artificial intelligence and big data in nanomedicine development.
Main Results:
- Nanoparticles enable targeted drug delivery, personalized treatment, and reduced toxicity.
- Postoperative nanomedicines can eliminate residual tumor cells, lower recurrence, and improve survival.
- Nanoparticle-based immunotherapy shows significant promise for osteosarcoma treatment.
Conclusions:
- Smart nanomedicine offers a transformative approach to osteosarcoma treatment, enhancing efficacy and patient outcomes.
- Further research is needed to address biosafety, ethical, and regulatory challenges for clinical translation.
- Optimizing nanocarrier targeting, biocompatibility, and integrating AI are crucial for future development.

